Ann Marie Navar

UT Southwestern · company speakers →

pharma-biotechhealthcare-services

Is this you? Claim this profile →

No public contact links on file.

Speaking history

Basic Cardiovascular Sciences Scientific Sessions

13 July 2026 Boston, United States “Efficacy and Safety of Enlicitide, an Oral PCSK9 Inhibitor, for Lowering LDL Cholesterol in Adults with or At-Risk for ASCVD: The Phase 3 CORALreef Lipids Trial”

Topics this speaker covers

pharma-biotechhealthcare-services

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →